The 74 Million – Asher Lehrer-Small
“Adolescents were met with welcome news in late March when Pfizer announced that its coronavirus vaccine was 100 percent effective in preventing infection among youth aged 12 to 15 in clinical trials. Shortly thereafter, the pharmaceutical company requested authorization from the FDA to expand use to that age group, a process that typically takes several weeks for review.” (more)